Advertisement
Subscribe now
Log in
October 28, 2024 15:50
E-Paper
E-Magazine
Corporate
CEO Talk
Biz Link
PR Newswire
Investing
M&A
Outbound Investment
Investing in Haiphong
Your Consultant
KPMG
PwC
RSM Vietnam
D.lion
Dentons LuatViet
Green Growth
Energy Efficiency
Rethinking Plastics
BASF
Property
Green Buildings
Industrial Properties
Money
Insurance
Smart Payment Trends
Stock Monitor
Infographics
Timeout
Travel
Hotels & Restaurants
The Insider
Entertainment
Lifestyle
Sports
Photos
Society
Swing for the Kids
CSR
World News
Tags
Caliway
Caliway completed CBL-514 phase 2b study for subcutaneous fat reduction
October 24, 2024 | 00:42
Caliway Biopharmaceuticals completed CBL-514 Phase 2b study for non-surgical fat reduction on October 22 nd, 2024, with the topline results anticipated in Q1 2025.
Latest News
Viettel Global's Q3 revenue increased by 25 per cent
Emes Engineering marks decade of sustainable development and resilience after COVID
Food market entices foreign business
Ca Mau ramps up preparations to achieve ambitions
Mobile Version